{
  "id": "clinical#screening_cues_179440ea",
  "content": "ium, see the criteria and discussion of delirium in the chapter “Neu-\nrocognitive Disorders.” These cannabis-induced disorders are\ndiagnosed instead of cannabis intoxication or cannabis withdrawal\nwhen the symptoms are sufficiently severe to warrant independent\nclinical attention.\n244 Substance-Related and Addictive Disorders\nUnspecified Cannabis-Related Disorder\n292.9 (F12.99)\nThis category applies to presentations in which symptoms character-\nistic of a cannabis-related disorder that cause clinically significant\ndistress or impairment in social, occupational, or other important ar-\neas of functioning predominate but do not meet the full criteria for any\nspecific cannabis-related disorder or any of the disorders in the sub-\nstance-related and addictive disorders diagnostic class.\nHallucinogen-Related Disorders\nPhencyclidine Use Disorder\nA. A pattern of phencyclidine (or a pharmacologically similar sub-\nstance) use leading to clinically significant impairment or dis-\ntress, as manifested by at least two of the following, occurring\nwithin a 12-month period:\n1. Phencyclidine is often taken in larger amounts or over a lon-\nger period than was intended.\n2. There is a persistent desire or unsuccessful efforts to cut\ndown or control phencyclidine use.\n3. A great deal of time is spent in activities necessary to obtain\nphencyclidine, use the phencyclidine, or recover from its ef-\nfects.\n4. Craving, or a strong desire or urge to use phencyclidine.\n5. Recurrent phencyclidine use resulting in a failure to fulfill ma-",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues ium, see the criteria and discussion of delirium in the chapter “Neu-\nrocognitive Disorders.” These cannabis-induced disorders are\ndiagnosed instead of cannabis intoxication or cannabis withdrawal\nwhen the symptoms are sufficiently severe to warrant independent\nclinical attention.\n244 Substance-Related and Addictive Disorders\nUnspecified Cannabis-Related Disorder\n292.9 (F12.99)\nThis category applies to presentations in which symptoms character-\nistic of a cannabis-related disorder that cause clinically significant\ndistress or impairment in social, occupational, or other important ar-\neas of functioning predominate but do not meet the full criteria for any\nspecific cannabis-related disorder or any of the disorders in the sub-\nstance-related and addictive disorders diagnostic class.\nHallucinogen-Related Disorders\nPhencyclidine Use Disorder\nA. A pattern of phencyclidine (or a pharmacologically similar sub-\nstance) use leading to clinically significant impairment or dis-\ntress, as manifested by at least two of the following, occurring\nwithin a 12-month period:\n1. Phencyclidine is often taken in larger amounts or over a lon-\nger period than was intended.\n2. There is a persistent desire or unsuccessful efforts to cut\ndown or control phencyclidine use.\n3. A great deal of time is spent in activities necessary to obtain\nphencyclidine, use the phencyclidine, or recover from its ef-\nfects.\n4. Craving, or a strong desire or urge to use phencyclidine.\n5. Recurrent phencyclidine use resulting in a failure to fulfill ma- Ium, see the criteria and discussion of delirium in the chapter “neu-\nrocognitive disorders.” these cannabis-induced disorders are\ndiagnosed instead of cannabis intoxication or cannabis withdrawal\nwhen the symptoms are s..."
}